Xspray Pharma

FDA

Pharma

After rejection, FDA accepts Xspray's leukemia med resubmission

With a patent feud settled and its application back at the FDA’s desk, Xspray believes it's on track to launch its first product late this summer.

Fraiser Kansteiner Feb 12, 2024 10:33am

Gavel with scales of justice in background

BMS settles with Xspray, clearing way for 2024 Dasynoc launch

Sep 12, 2023 10:16am

Stop sign

FDA rejects Xspray's would-be rival to BMS leukemia med Sprycel

Jul 11, 2023 9:55am